CD4 and anal carcinoma: Piketty et al, showed that the incidence of anal cancer was higher in HIV-infected patients particularly in MSM (men who have sex with men) and the incidence of anal HPV infections did not reduce despite the increased CD4+ T cell count following cART [51], suggesting that cART- associated immune restoration does not play a role in reduction of the incidence of anal cancers [52].